A molecular profile that predicts response to platinum based chemotherapy in non-small cell lung cancer (NSCLC) patients

被引：0
|
作者：
Petty, RD
Murray, GI
Kerr, K
Nicolson, MC
Bissett, JD
Collie-Duguid, E
机构：
[1] Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland
[2] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
[3] Aberdeen Royal Infirm, Dept Oncol, Aberdeen, Scotland
来源：
BRITISH JOURNAL OF CANCER | 2004年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [21] DECREASE OF CIRCULATING TUMOR CELLS ASSOCIATES WITH RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER, BUT NOT WITH SMALL CELL LUNG CANCER
    Gauler, Thomas C.
    Theegarten, Dirk
    Parr, Annette
    Schuhr, Ivonne
    Schmid, Kurt W.
    Eberhardt, Wilfried
    Schuler, Martin
    Hoffmann, Andreas-Claudius
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1114 - S1114
  • [22] NANOG Predicts Poor Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Lee, Seung Hyeun
    Park, Myung Jae
    Park, So Young
    In, Kwang Ho
    Kim, Chul Hwan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S959 - S960
  • [23] Adjuvant Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Preoperative Chemotherapy
    Deng, L.
    Jiang, C.
    Perimbeti, S.
    Chen, H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S234 - S234
  • [24] Gefitinib and celecoxib in patients with platinum refractory non-small cell lung cancer (NSCLC).
    Gadgeel, SM
    Shehadeh, NJ
    Ruckdeschel, JC
    Chaplen, RA
    Belzer, K
    Wozniak, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 639S - 639S
  • [25] Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet
    Kozlowska, Emilia
    Suwinski, Rafal
    Giglok, Monika
    Swierniak, Andrzej
    Kimmel, Marek
    PLOS COMPUTATIONAL BIOLOGY, 2020, 16 (10)
  • [26] Predicting the response to chemotherapy in patients with non-small cell lung cancer
    Wislez, M.
    Antoine, M.
    Lavole, A.
    Gounant, V.
    Milleron, B.
    Cadranel, J.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S206 - S210
  • [27] Maintenance chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC)
    Belalcazar, A.
    Santos, E. S.
    Gomez, J. E.
    Lopez, E.
    Raez, L. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [29] MOLECULAR MARKERS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Heigener, D.
    ANTICANCER RESEARCH, 2011, 31 (05) : 1979 - 1979
  • [30] Outcomes of patients undergoing adjuvant platinum-vinorelbine chemotherapy for resected non-small cell lung cancer (NSCLC)
    Pender, A.
    Coward, J.
    Gunapala, R.
    Bhosle, J.
    O'Brien, M.
    Popat, S.
    LUNG CANCER, 2013, 79 : S12 - S12
12345